Cargando…

Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections

Herpes simplex virus (HSV) usually produces cytopathic effect (CPE) within 24-72 h post-infection (P.I.). Clinical isolates from recurrent HSV infections in patients on Acyclovir therapy were collected between 2016 and 2019 and tested in cell cultures for cytopathic effects and further in-depth char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Subrata, Sukla, Soumi, De, Abhishek, Biswas, Subhajit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789845/ https://www.ncbi.nlm.nih.gov/pubmed/35079057 http://dx.doi.org/10.1038/s41598-022-05188-w

Ejemplares similares

Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study
por: De, Abhishek, et al.
Publicado: (2017)

Presumed herpes simplex virus ulcerative nodular episcleritis treated by topical acyclovir alone
por: Hoshing, Abhishek, et al.
Publicado: (2022)

Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?
por: Nath, Himadri, et al.
Publicado: (2020)

Thrombocytopenia Secondary to Herpes Simplex Virus-2 Infection Successfully Treated by Acyclovir
por: Siddiqui, Raheel S, et al.
Publicado: (2020)

Neonatal Herpes Simplex Fulminant Hepatitis Successfully Treated with Acyclovir
por: Abuhasna, Said D., et al.
Publicado: (2012)

Isolation, characterization and acyclovir susceptibility of herpes simplex virus isolates among immunocompromised patients
por: Nag, Soumyabrata, et al.
Publicado: (2021)

Necrotizing Keratitis Caused by Acyclovir-Resistant Herpes Simplex Virus
por: Toriyama, Koji, et al.
Publicado: (2014)

Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir
por: Enescu, Christina D., et al.
Publicado: (2021)

Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152–4. https://doi.org/10.1016/j.ijid.2020.10.043
por: Biswas, Subhajit, et al.
Publicado: (2021)

Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients
por: Mitterreiter, Johanna G., et al.
Publicado: (2016)

Acyclovir resistance in herpes simplex virus type I encephalitis: a case report
por: Bergmann, M., et al.
Publicado: (2016)

Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
por: Michaelis, Martin, et al.
Publicado: (2019)

Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests
por: Nath, Himadri, et al.
Publicado: (2021)

Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient
por: Tan, Charlie, et al.
Publicado: (2023)

COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
por: Nath, Himadri, et al.
Publicado: (2022)

Alopecia Following Oral Acyclovir for the Treatment of Herpes Simplex Keratitis
por: Sharma, Ashok, et al.
Publicado: (2014)

Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis
por: Dutt, Surabhi, et al.
Publicado: (2016)

A Rare Case of Congenital Herpes Simplex Virus Infection with Therapeutic Response to Acyclovir
por: Jangid, Neha C., et al.
Publicado: (2023)

Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy
por: Harada, Yukinori, et al.
Publicado: (2017)

A Rapid and Easy-to-Perform Method of Nucleic-Acid Based Dengue Virus Diagnosis Using Fluorescence-Based Molecular Beacons
por: Sukla, Soumi, et al.
Publicado: (2021)

Inactivation of acyclovir-sensitive and -resistant strains of herpes simplex virus type 1 in vitro by photodynamic antimicrobial chemotherapy
por: Latief, Miftahul Akhyar, et al.
Publicado: (2015)

The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2014)

Synergistic effects of acyclovir and 3, 19- isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains
por: Priengprom, Thongkoon, et al.
Publicado: (2015)

Implementation of In-house PCR Testing for Herpes Simplex Virus Encephalitis: Impact on Patient Acyclovir Exposure
por: Beaulieu, Ronald, et al.
Publicado: (2017)

Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis
por: Ramakrishna, Chandran, et al.
Publicado: (2020)

1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series
por: Albrecht, Kim WorkowskiJoerg, et al.
Publicado: (2021)

Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence
por: Omura, Natsumi, et al.
Publicado: (2017)

Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity
por: Kalke, Kiira, et al.
Publicado: (2020)

Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections
por: Chaudhary, Binu, et al.
Publicado: (2014)

Empirical treatment with parenteral acyclovir in a child with herpes simplex virus hepatitis and acute lymphoblastic leukemia
por: Faqih, Nesreen A., et al.
Publicado: (2018)

1760. Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Hematologic Malignancies and Hematopoietic Cell Transplant
por: Ross, Justine Abella, et al.
Publicado: (2019)

Acyclovir suppression to prevent recurrent genital herpes at delivery.
por: Scott, L L, et al.
Publicado: (2002)

Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections
por: Al-Subaie, Mutlaq M, et al.
Publicado: (2015)

Impact of acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication
por: Schuierer, Lukas, et al.
Publicado: (2020)

Role of Intravenous Acyclovir in Treatment of Herpes Simplex Virus Stromal Keratitis with Ulceration: A Review of 2 Cases
por: Pisitpayat, Punyanuch, et al.
Publicado: (2021)

Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1, HSV-2) Infection in Cultured Cells
por: Panteva, M., et al.
Publicado: (1998)

Silicone-Acyclovir Controlled Release Devices Suppress Primary Herpes Simplex Virus-2 and Varicella Zoster Virus Infections In Vitro
por: Berkower, Carol L., et al.
Publicado: (2013)

609. Acute Kidney Injury During Treatment with Intravenous Acyclovir (AKITA) for Suspected Neonatal Herpes Simplex Virus Infection
por: Haltzman, Brittany L, et al.
Publicado: (2018)

Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections
por: Birkmann, Alexander, et al.
Publicado: (2022)

Variant Analysis of the Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus in Korea: Frequency of Acyclovir Resistance Mutations
por: Hyun, Jungwon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j839obhfhgblc2hkke5qrujcb3